Filing Details
- Accession Number:
- 0000947871-16-001452
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-24 16:36:38
- Reporting Period:
- 2016-08-22
- Filing Date:
- 2016-08-24
- Accepted Time:
- 2016-08-24 16:36:38
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1597313 | Viewray Inc. | VRAY | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1572451 | P David Bonita | C/O Viewray, Inc. 2 Thermo Fisher Way Oakwood Village OH 44146 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2016-08-22 | 1,127,338 | $2.95 | 9,041,883 | No | 4 | P | Indirect | See Footnotes |
Common Stock, Par Value $0.01 Per Share | Acquisiton | 2016-08-22 | 10,736 | $2.95 | 86,107 | No | 4 | P | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnotes |
No | 4 | P | Indirect | See Footnotes |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants to purchase common stock | Acquisiton | 2016-08-22 | 338,201 | $0.13 | 338,201 | $2.95 |
Common Stock | Warrants to purchase common stock | Acquisiton | 2016-08-22 | 3,220 | $0.13 | 3,220 | $2.95 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
338,201 | 2016-08-22 | 2023-08-22 | No | 4 | P | Indirect |
3,220 | 2016-08-22 | 2023-08-22 | No | 4 | P | Indirect |
Footnotes
- These securities are held of record by OrbiMed Private Investments III, LP ("OPI III") and may be deemed to be indirectly beneficially owned by OrbiMed Capital GP III LLC ("GP III"), OrbiMed Advisors LLC ("Advisors") and Samuel D. Isaly ("Isaly"). GP III is the sole general partner of OPI III. Advisors, a registered adviser under the Investment Advisers Act of 1940, as amended, is the sole managing member of GP III. By virtue of such relationships, GP III and Advisors may be deemed to have voting and investment power with respect to the securities held by OPI III noted above. The reporting person is an employee of Advisors.
- These securities are held of record by OrbiMed Associates III, LP ("Associates III") and may be deemed to be indirectly beneficially owned by Advisors and Isaly. Advisors is the sole general partner of Associates III. Isaly is the managing member of, and holder of a controlling interest in, Advisors. By virtue of such relationship, Advisors and Isaly may be deemed to have voting and investment power with respect to the securities held by Associates III noted above. As a result, each of Advisors and Isaly may be deemed to have beneficial ownership of the securities held by Associates III.
- Each of the Reporting Person, GP III, Advisors, and Isaly disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Exchange Act, except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any such entity or person, including the Reporting Person, is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.